Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab

A 69-year-old man with stage III lung squamous cell carcinoma developed immune-related hepatitis following treatment with durvalumab, and was given high-dose corticosteroids and immunosuppressive drugs (mycophenolate mofetil, azathioprine, tacrolimus) but without demonstrating any improvement. Two c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Koki, Demura, Yoshiki, Oi, Masahiro, Tabata, Mio, Tada, Toshihiko, Shiozaki, Kohei, Akai, Masaya, Ishizuka, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759708/
https://www.ncbi.nlm.nih.gov/pubmed/32727989
http://dx.doi.org/10.2169/internalmedicine.5216-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759708/
https://www.ncbi.nlm.nih.gov/pubmed/32727989
http://dx.doi.org/10.2169/internalmedicine.5216-20

Ejemplares similares